Ante una vacuna eficaz contra el Ébola (comunicado de la OMS)
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international…

